BP000228-CYT-601: Recombinant Human Epigen
Source: E. coli-derived.
Determined by the dose-dependent stimulation of the proliferation of murine Balb/3T3 cells. The expected ED50 for this effect is 150-300 ug/ml corresponding to a specific activity of 3,334-6,667 IU/mg.
Purity > 98%, by SDS-PAGE and RP-HPLC.BP000590-PKA-335: Recombinant Human EGFR Sf9, Active
Source: Baculovirus infected Sf9 cells-derived.
Specific activity: 30 pmol/µgxmin.BP000590-PKA-344: Recombinant Human EGFR Sf9
Source: Sf9 Insect Cells-derived.
Purity > 90%, by SDS-PAGE.BP000970-PKA-340: Recombinant Human C-erbB2 Protein
Source: E.coli-derived.
Purity > 95%, by SDS-PAGE.BP000971-PKA-343: Recombinant Human ErbB-2
Source: E. coli-derived.
Purity > 95%, by SDS-PAGE.BP000972-PKA-342: Recombinant Human Tyrosine Kinase ErbB-3
Source: E. coli-derived.
Measured by its ability to postpone tumor emerge time of spontaneous breast cancer in FVB/N transgenic mice and inhibit the development of tumor, effectively inhibit the growth of in situ transplanted breast cancer in FVB/N transgenic mice.
Purity > 95%, by RP-HPLC and SDS-PAGE.BP001005-CYT-407: Recombinant Human NRG1
Source: E. coli-derived.
The activity measured by its ability to stimulate the proliferation of human MCF-7 cells grown under serum-free conditions corresponding to a specific activity of 12,000 Units/mg.
Purity > 96%, by SDS?PAGE and RP-HPLC.BP002919-PRO-782: Recombinant Human Proliferation-associated protein 2G4 (PA2G4) Protein
Source: E. coli-derived.
Purity: >95.0% as determined by SDS-PAGE.BP002697-PRO-1148: Recombinant Human Mediator of Cell Motility 1 (MEMO1) protein
Source: Escherichia Coli-derived.
Purity: > 95.0% by SDS-PAGE.C002: Erbitux Biosimilar Stable Cell Line (CHO)
The yield of Erbitux biosimilar from the CHO stable cell line was above 1.7 g/L in a 750 liter manufacturing.